Remus Pharmaceuticals
Remus Pharmaceuticals Performance
Day Range
- Low 4815
- High 5041.95
52 Week Range
- Low 1711.25
- High 5041.95
- Open Price4890
- Previous Close4803.95
- Volume10500
Start SIP in Remus Pharmaceuticals
Start SIPRemus Pharmaceuticals Investment Rating
-
Master Rating:
-
Remus Pharmaceuticals Ltd has an operating revenue of Rs. 100.08 Cr. on a trailing 12-month basis. An annual revenue growth of 83% is outstanding, Pre-tax margin of 25% is great, ROE of 44% is exceptional. The company has a reasonable debt to equity of 37%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 14% and 28% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 77 which is a FAIR score but needs to improve its earnings, a RS Rating of 95 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 18 indicates it belongs to a strong industry group of Medical-Whlsle Drg/Suppl and a Master Score of A is the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Mar 2022 |
|---|---|---|
| Total Revenue Annual Cr | 47 | 25 |
| Operating Expenses Annual Cr | 34 | 21 |
| Operating Profit Annual in Cr | 11 | 4 |
| Depreciation Cr | 0 | 0 |
| Interest Annual Cr | 0 | 0 |
| Tax Annual Cr | 3 | 1 |
| Net Profit Annual Cr | 9 | 3 |
Remus Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹4440.49
- 50 Day
- ₹4123.98
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹4369.8
- 50 Day
- ₹4238.65
- 100 Day
- ₹
- 200 Day
- ₹
Remus Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹5046.34 |
| Second Resistance | ₹5157.62 |
| Third Resistance | ₹5273.29 |
| RSI | 69.83 |
| MFI | 76.97 |
| MACD Single Line | 66.02 |
| MACD | 118.98 |
| Support | |
|---|---|
| First Resistance | ₹4819.39 |
| Second Resistance | ₹4703.72 |
| Third Resistance | ₹4592.44 |
Remus Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 10,500 | 929,985 | 88.57 |
| Week | 6,740 | 576,000 | 85.46 |
| 1 Month | 3,838 | 304,745 | 79.4 |
| 6 Month | 6,008 | 496,332 | 82.61 |
Remus Pharmaceuticals Result Highlights
Remus Pharmaceuticals Synopsis
NSE-Medical-Whlsle Drg/Suppl
Remus Pharmaceutic belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 45.03 Cr. and Equity Capital is Rs. 1.09 Cr. for the Year ended 31/03/2023. Remus Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24232GJ2015PLC084536 and registration number is 084536.| Market Cap | 727 |
| Sales | 45 |
| Shares in Float | 0.05 |
| No of funds | 19 |
| Yield |
| Book Value | 27.98 |
| U/D Vol ratio | 1.6 |
| LTDebt / Equity | 37 |
| Alpha | 1.13 |
| Beta | 1.61 |
Remus Pharmaceuticals
| Owner Name | May-23 |
|---|---|
| Promoters | 68.37% |
| Foreign Portfolio Investors | 2.55% |
| Financial Institutions/ Banks | 0.92% |
| Individual Investors | 16.69% |
| Others | 11.47% |
Remus Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Swapnil Jatinbhai Shah | Chairman & Wholetime Director |
| Mr. Arpit Deepakkumar Shah | Managing Director |
| Mrs. Anar Swapnil Shah | Whole Time Director |
| Ms. Roma Vinodbhai Shah | Whole Time Director |
| Mr. Balwant Purohit | Independent Director |
| Mrs. Sanjana Sanjeev Shah | Independent Director |
| Mr. Vishrut Chandramauli Pathak | Independent Director |
Remus Pharmaceuticals Forecast
Price Estimates
- Company Name
- CMP
- Chg(%)
- Eicher Motors
- 3472
- 2.5
- Hero Motocorp
- 3034
- 2.0
- Nestle India
- 23006
- 1.6
- Bajaj Auto
- 5069
- 1.3
- O N G C
- 188
- 1.2
- Company Name
- CMP
- Chg(%)
- IndusInd Bank
- 1423
- -1.4
- Cipla
- 1164
- -1.3
- Tech Mahindra
- 1282
- -1.3
- Kotak Mah. Bank
- 1764
- -1.1
- Adani Enterp.
- 2458
- -1.0
Remus Pharmaceuticals FAQs
What is Share Price of Remus Pharmaceuticals ?
Remus Pharmaceuticals share price is ₹4935 As on 27 September, 2023 | 00:57
What is the Market Cap of Remus Pharmaceuticals ?
The Market Cap of Remus Pharmaceuticals is ₹726.9 Cr As on 27 September, 2023 | 00:57
What is the P/E ratio of Remus Pharmaceuticals ?
The P/E ratio of Remus Pharmaceuticals is As on 27 September, 2023 | 00:57
What is the PB ratio of Remus Pharmaceuticals ?
The PB ratio of Remus Pharmaceuticals is 38 As on 27 September, 2023 | 00:57